Bibliography
Lunkes, A., Lindenberg, K. S., Ben-HaıÌem, L., Weber, C., Devys, D., Landwehrmeyer, G. B., Mandel, J.-L., & Trottier, Y. (2002). Proteases Acting on Mutant Huntingtin Generate Cleaved Products that Differentially Build Up Cytoplasmic and Nuclear Inclusions. Molecular Cell, 10(2), 259â269.
References
37
Referenced
327
10.1006/jsbi.2000.4332
/ J. Struct. Biol. / The MEROPS database as a protease information system by Barrett (2001)10.1126/science.292.5521.1552
/ Science / Impairment of the ubiquitin-proteasome system by protein aggregation by Bence (2001)10.1093/emboj/21.1.31
/ EMBO J. / A masked NES in INI1/hSNF5 mediates hCRM1-dependent nuclear export by Craig (2002)10.1016/S0092-8674(00)80513-9
/ Cell / Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation by Davies (1997)10.1126/science.277.5334.1990
/ Science / Aggregation of Huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain by Di Figlia (1997)10.1098/rstb.1999.0459
/ Philos. Trans. R. Soc. Lond. B Biol. Sci. / Analysis of the subcellular localization of huntingtin with a set of rabbit polyclonal antibodies in cultured mammalian cells of neuronal origin by Dorsman (1999)10.1074/jbc.272.19.12778
/ J. Biol. Chem. / Cleavage site for sterol-regulated protease localized to a leu-Ser bond in the lumenal loop of sterol regulatory element-binding protein-2 by Duncan (1997)10.1074/jbc.273.28.17801
/ J. Biol. Chem. / Second-site cleavage in sterol regulatory element-binding protein occurs at transmembrane junction as determined by cysteine panning by Duncan (1998)10.1038/ng745
/ Nat. Genet. / Mutant protein in Huntington disease is resistant to proteolysis in affected brain by Dyer (2001)10.1523/JNEUROSCI.19-07-02522.1999
/ J. Neurosci. / Nuclear and neuropil aggregates in Huntington's disease by Gutekunst (1999)10.1083/jcb.141.5.1097
/ J. Cell Biol. / The influence of huntingtin protein size on nuclear localization and cellular toxicity by Hackam (1998)10.1093/hmg/8.1.25
/ Hum. Mol. Genet. / In vitro evidence for both the nucleus and cytoplasm as subcellular sites of pathogenesis in Huntington's disease by Hackam (1999)10.1006/bbrc.2000.3682
/ Biochem. Biophys. Res. Commun. / Formic acid dissolves aggregates of an N-terminal huntingtin fragment containing an expanded polyglutamine tract by Hazeki (2000)10.1016/S0896-6273(00)80764-3
/ Neuron / A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration by Hodgson (1999)10.1093/hmg/10.10.1049
/ Hum. Mol. Genet. / Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c release by Jana (2001)10.1523/JNEUROSCI.20-19-07268.2000
/ J. Neurosci. / Huntingtin expression stimulates endosomal-lysosomal activity, endosome tubulation, and autophagy by Kegel (2000)10.1073/pnas.221451398
/ Proc. Natl. Acad. Sci. USA / Caspase 3-cleaved N-terminal fragments of wild-type and mutant huntingtin are present in normal and Huntington's disease brains, associate with membranes, and undergo calpain-dependent proteolysis by Kim (2001)10.1016/S0092-8674(00)81781-X
/ Cell / Ataxin-1 nuclear localization and aggregation by Klement (1998)10.1073/pnas.96.6.3053
/ Proc. Natl. Acad. Sci. USA / Mechanism of the cleavage specificity of Alzheimer's disease gamma-secretase identified by phenylalanine-scanning mutagenesis of the transmembrane domain of the amyloid precursor protein by Lichtenthaler (1999)10.1093/hmg/7.9.1355
/ Hum. Mol. Genet. / A cellular model that recapitulates major pathogenic steps of Huntington's disease by Lunkes (1998){'key': '10.1016/S1097-2765(02)00602-0_BIB21', 'first-page': '30', 'article-title': "Cellular models of Huntington's disease", 'volume': '3', 'author': 'Lunkes', 'year': '2000', 'journal-title': 'Neuroscience News'}
/ Neuroscience News / Cellular models of Huntington's disease by Lunkes (2000)10.1098/rstb.1999.0453
/ Philos. Trans. R. Soc. Lond. B Biol. Sci. / Properties of polyglutamine expansion in vitro and in a cellular model for Huntington's disease by Lunkes (1999)10.1523/JNEUROSCI.21-06-01830.2001
/ J. Neurosci. / Tissue-specific proteolysis of Huntingtin (htt) in human brain by Mende-Mueller (2001)10.1093/hmg/10.14.1441
/ Hum. Mol. Genet. / SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein by Nakamura (2001)10.1083/jcb.143.6.1457
/ J. Cell Biol. / Recruitment and the role of nuclear localisation in polyglutamine-mediated aggregation by Perez (1998)10.1073/pnas.91.12.5355
/ Proc. Natl. Acad. Sci. USA / Glutamine repeats as polar zippers by Perutz (1994)10.1016/S0092-8674(00)80514-0
/ Cell / Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo by Scherzinger (1997)10.1073/pnas.89.13.6075
/ Proc. Natl. Acad. Sci. USA / Beta-amyloid precursor protein cleavage by a membrane-bound protease by Sisodia (1992)10.1073/pnas.100110097
/ Proc. Natl. Acad. Sci. USA / The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription by Steffan (2000)10.1083/jcb.153.2.283
/ J. Cell Biol. / Identities of sequestered proteins in aggregates from cells with induced polyglutamine expression by Suhr (2001)10.1038/ng0595-104
/ Nat. Genet. / Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated form by Trottier (1995)10.1038/378403a0
/ Nature / Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias by Trottier (1995)10.1097/00005072-198511000-00003
/ J. Neuropathol. Exp. Neurol. / Neuropathological classification of Huntington's disease by Vonsattel (1985)10.1074/jbc.M001475200
/ J. Biol. Chem. / Inhibiting caspase cleavage of huntingtin reduces toxicity and aggregate formation in neuronal and nonneuronal cells by Wellington (2000)10.1093/hmg/9.4.503
/ Hum. Mol. Genet. / Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice by Wheeler (2000)10.1016/S0092-8674(00)80623-6
/ Cell / Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease by Yamamoto (2000)10.1146/annurev.neuro.23.1.217
/ Annu. Rev. Neurosci. / Glutamine repeats and neurodegeneration by Zoghbi (2000)
Dates
Type | When |
---|---|
Created | 21 years, 4 months ago (April 20, 2004, 8:48 p.m.) |
Deposited | 6 years, 6 months ago (Feb. 10, 2019, 5:53 a.m.) |
Indexed | 4 days, 12 hours ago (Aug. 19, 2025, 7 a.m.) |
Issued | 23 years ago (Aug. 1, 2002) |
Published | 23 years ago (Aug. 1, 2002) |
Published Print | 23 years ago (Aug. 1, 2002) |
@article{Lunkes_2002, title={Proteases Acting on Mutant Huntingtin Generate Cleaved Products that Differentially Build Up Cytoplasmic and Nuclear Inclusions}, volume={10}, ISSN={1097-2765}, url={http://dx.doi.org/10.1016/s1097-2765(02)00602-0}, DOI={10.1016/s1097-2765(02)00602-0}, number={2}, journal={Molecular Cell}, publisher={Elsevier BV}, author={Lunkes, Astrid and Lindenberg, Katrin S. and Ben-Haı̈em, Léa and Weber, Chantal and Devys, Didier and Landwehrmeyer, G.Bernhard and Mandel, Jean-Louis and Trottier, Yvon}, year={2002}, month=aug, pages={259–269} }